U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 143

Tests names and labsConditionsGenes, analytes, and microbesMethods

Myelogenous leukemia, acute (IRF1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980, Autosomal recessive (EGFR gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Nonsmall cell lung cancer, susceptibility to, 211980, Autosomal recessive (EGFR gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Nonsmall cell lung cancer, somatic, 211980 (IRF1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Adenocarcinoma of lung, somatic, 211980 (BRAF V600E - 599 ve 601. codons mutations - Exon 15 mutations) (BRAF gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Adenocarcinoma of lung, somatic, 211980 (PRKN gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Top 99 Genetic Causes of Developmental Delay Panel

PreventionGenetics, part of Exact Sciences
United States
17099
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

KRAS, BRAF, and NRA Mutation Analysis

PathGroup
United States
233
  • T Targeted variant analysis

BRAF and MSI Mutation Analysis

PathGroup
United States
151
  • I Microsatellite instability testing (MSI)
  • T Targeted variant analysis

KRAS, BRAF, NRAS and MSI Mutation Analysis

PathGroup
United States
233
  • T Targeted variant analysis

BRAF, NRAS, KIT Mutation Analysis

PathGroup
United States
163
  • T Targeted variant analysis

BRAF, EGFR, KRAS Mutation Analysis

PathGroup
United States
253
  • T Targeted variant analysis

Basic Lung Profile

PathGroup
United States
152
  • T Targeted variant analysis

ALK ROS1 Fusion Test

Circulogene Theranostics
United States
52
  • R RNA analysis

PrimBio Cancer HotSpot Panel

PrimBio Research Institute
United States
6050
  • T Targeted variant analysis

NoonanNextâ„¢

Ambry Genetics
United States
2018
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hypomagnesemia Panel

PreventionGenetics, part of Exact Sciences
United States
1616
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1652
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

BRAF Sequence Analysis (Prenatal Diagnosis)

Baylor Genetics
United States
41
  • T Targeted variant analysis

BRAF Sequence Analysis (Familial Mutation/Variant Analysis)

Baylor Genetics
United States
41
  • T Targeted variant analysis

Results: 21 to 40 of 143

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.